Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1.]
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial, Surgeons., American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the, jaws.
J Oral Maxillofac, Surg, (2007), 65 pp. 369-376
[2.]
J. Bagan, J. Blade, J.M. Cozar, M. Constela, R. García Sanz, F. Gómez Veiga, et al.
Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Med Oral Patol Oral Cir Bucal, (2007), 12 pp. E336-E340
[3.]
J.V. Bagan, P. Diz Dios, L. Gallego, P. Infante-Cossio, Y. Jiménez, L.M. Junquera, et al.
Recomendaciones para la prevención de la osteonecrosis de los maxilares (ONM) en pacientes tratados con bisfosfonatos intravenosos.
Med Oral Patol Oral Cir Bucal, (2008), 13 pp. 161-167
[4.]
S. Khosla, D. Burr, J. Cauley, D.W. Dempster, P.R. Ebeling, D. Felsenberg, et al.
American Society for Bone and Mineral Research Task Force on Osteonecrosis of the Jaw Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
J Oral Maxillofac Surg, (2008), 66 pp. 1320-1321
[5.]
R.E. Marx, J.E. Cillo Jr., J.J. Ulloa.
Oral bisphosphonate-induced osteonecrosis:.risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
J Oral Maxillofac Surg, (2007), 65 pp. 2397-2410
[6.]
H.C. Schwartz.
Serum CTX testing.
J Oral Maxillofac Surg, (2008), 66 pp. 1319-1320
[7.]
L.A. Assael, C.T.X. Serum.
to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?.
J Oral Maxillofac Surg, (2007), 65 pp. 2395-2396
[8.]
J.V. Bagan, Y. Jiménez, D. Gómez, R. Sirera, R. Poveda, C. Scully.
Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.
Oral Oncol, (2008), 44 pp. 1088-1089
[9.]
C. Lee, J.B. Suzuki.
CTX biochemical marker of bone metabolism Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery?. Part I: biological concepts with a review of the literature.
Implant Dentistry, (2009), 18 pp. 492-498
[10.]
C. Lee, J.B. Suzuki.
CTX biochemical marker of bone metabolism Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery?. Part II: A prospective clinical study.
Implant Dentistry, (2010), 19 pp. 29-35
[11.]
M. Sosa, M.J. Gómez de Tejada, J.V. Bagán, M. Díaz, A. Díez, E. Jódar, et al.
Osteonecrosis of the Jaw.
Rev Osteoporos Metab Miner, (2009), 1 pp. 41-51
[12.]
F. Dore, L. Filippi, M. Biasotto, S. Chiandussi, F. Cavalli, R. Di Lenarda.
Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
J Nucl Med, (2009), 50 pp. 30-35
[13.]
R. Fabbricini, L. Catalano, L. Pace, S. del Vecchio, R. Fonti, M. Salvatore, et al.
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw.
J Nucl Med, (2009), 50 pp. 1385
[14.]
L. Junquera, L. Gallego.
Non exposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?.
J Oral Maxillofac Surg, (2008), 66 pp. 1516-1517
[15.]
E. Carbonel, J.M. Díaz, J. Murillo.
Tratamiento de la osteonecrosis de los maxilares por bisfosfonatos.
Osteonecrosis de los maxilares por bisfosfonatos, Medicina Oral SL, pp. 71-90
[16.]
J.V. Bagan, Y. Jiménez, J.M. Díaz, J. Murillo, J.M. Sanchis, R. Poveda, et al.
Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification.
Oral Oncol, (2009), 45 pp. 645-646
[17.]
S. Bocanegra-Pérez, M. Vicente-Barrero, M. Knezevic, J.M. Castellano-Navarro, E. Rodríguez-Bocanegra, J. Rodríguez-Millares, et al.
Use of platelet- rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw.
Int J Oral Maxillofac Surg, (2012), 41 pp. 1410-1415
[18.]
S. Bocanegra-Pérez, M. Vicente-Barrero, M. Sosa-Hernández, M. Knezevic, J.M. Castellano-Navarro, J. Rodríguez-Millares.
Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment.
Med Oral Patol Oral Cir Bucal, (2008), 13 pp. E770-E773
[19.]
M. Sosa-Henríquez, M.J. Gómez de Tejada-Romero, J.V. Bagán-Sebastián, M. Díaz-Curiel, A. Díez-Pérez, et al.
Osteonecrosis de los maxilares: Documento de consenso.
Rev Osteoporos Metab Miner, (2009), 1 pp. 41-51
Copyright ©
2014. Elsevier España, S.L.. Todos los derechos reservados
